and swingers yielded more than half of all anorectal STD infections and is more sensitive for identifying anorectal STD infections compared with selective testing. Universal testing may be a more effective strategy for interrupting the ongoing transmission in high-risk sexual networks.
S
exually transmitted diseases (STDs) at extragenital sites are common. Studies found anorectal STD in up to 21% of men having sex with men (MSM) 1Y8 and women. 8Y13 Early detection and treatment are critical strategies in STD control to prevent medical complications and reduce transmission. 7 Therefore, availability of an appropriate diagnostic test is essential. The highly sensitive and specific nucleic acid amplification tests (NAATs) are superior to culture for extragenital Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) detection.
14 US Centers for Disease Control guidelines advocate annual testing for CT and NG in sexually active women and/ or women younger than 26 years 15 but make no recommendations on anatomical site-specific testing in this group. For sexually active MSM, US Centers for Disease Control guidelines advocate anatomical site-specific testing for CT and NG based on sexual history, that is, urogenital testing after insertive anal intercourse, anorectal testing after receptive anal intercourse, and oropharyngeal testing after oral intercourse. World Health Organization guidelines for MSM and transgender individuals advocate periodic testing for asymptomatic urogenital and anorectal CT and NG. 16 Dutch guidelines recommend anorectal testing in those with a history of anal sex and/or symptoms, as well as oropharyngeal testing after self-reported oral sex. 17 However, heterosexual men and women were not often tested anorectally and/or oropharyngeally. 8, 18 Prior clinical studies document high rates of missed extragenital CT/NG by urogenital testing only in MSM 1,3Y8 and women. 8Y10,12,13 However, these studies relied on selective testing based on history of anal sex and/or symptoms. Anorectal CT/NG infections are very likely to be asymptomatic, 1 and history of sexual behavior seems to be an unreliable triaging tool for anatomical site-specific testing.
2 Reliability may be compromised by underreporting of specific sexual practices or improper history taking. Two other studies universally screened MSM for oropharyngeal CT/NG, 19, 20 and 1 study universally screened HIV positives for anorectal and oropharyngeal CT/NG. 21 To date, there have been no studies comparing symptom-and/or sexual historyY based testing with universal testing at anorectal site in MSM and swingers. Swingers are heterosexual couples who have sex with other heterosexual couples and their self-identified heterosexual sex partners. Swingers differ from nonswinging heterosexual adults by their sexual network, characterized by concurrent sexual partners and high rates of unprotected sex. This makes swingers more prone to CT/NG. 22 With current testing practices, many anorectal CT/NG cases are likely to be missed, resulting in underestimated prevalence and ongoing transmission in high-risk populations. In this study, we determined the sensitivity of symptom-and sexual historyYbased testing,
MATERIALS AND METHODS
The South Limburg Public Health Service's STD unit provides more than 6000 consults annually, offering free examination and treatment at 3 regional outpatient STD clinics.
Study Population
Between January 2010 and February 2011, MSM and male and female swingers were universally tested for CT and NG at 3 anatomical sitesVurogenital, anorectal, and oropharyngealV yielding a total of 1690 consults for analysis. Individuals younger than 18 years were excluded from analysis on medical ethical grounds. Risk group allocation was performed routinely in all attendees at each consult, based on self-reported sexual behavior, in accordance with national testing guidelines. Men having sex with men were defined as men who had sex with 1 or more men in the past 6 months. An individual was registered as a swinger when he or she reported to be part of a male-female couple, who, as a couple, had sex with other male-female couples, or when he or she reported to be a swinger's heterosexual sex partner. Although swingers, by definition, have a heterosexual orientation, their sexual behavior may include same-sex activities. Swingers form their sexual networks, especially at physical venues such as swingers clubs or erotic parties and virtual venues, for example, specific dating Web sites.
Study Procedures
Specimens to be tested were self-collected vaginal swabs, anorectal swabs, oropharyngeal swabs, and urine and, in a minority of cases, clinician-collected urethral and cervical swabs. Specimens were processed at 2 regional laboratories using 2 different nucleic acid amplification assays (strand displacement amplification [Becton Dickinson ProbeTec ET system, Sparks, MD] and polymerase chain reaction [PCR; Roche Cobas Amplicor, San Francisco, CA], respectively). The rationale for using NAAT assays for testing extragenital specimens is that they have demonstrated higher sensitivity compared with culture. 23 Each of the 2 laboratories performed approximately half of all tests included in our study. Laboratory selection was based on the geographical location of the STD clinic and independent of risk group, anatomical site tested, or day and month of testing. All NG-positive samples were confirmed with an in-house PCR. 24 Serum was tested for Treponema pallidum hemagglutination (TPHA) and HIV (anti-HIV[1/2], Axsym; Abbott Laboratories, Chicago, IL). Reactive samples were confirmed using Western blot (HIVblot 2.2; Genelabs Diagnostics, Science Park, Singapore), according to the manufacturer's protocol. Besides testing, each consult included the taking of a standardized medical and sexual history by trained study nurses, including demographic data, self-reported symptoms, and sexual behavior in the preceding 6 months. All data were registered in an electronic patient registry.
Variables
Risk group category was hierarchically constructed based on self-reported sexual behavior that is associated with sexual preference and sex of the sex partner(s). Each participant/ attendee was allocated to 1 of the after nonoverlapping groups: MSM who only had sex with men (homosexual MSM), MSM who had sex with both men and women (bisexual MSM), male swingers who had sex with both men and women (bisexual male swingers), male swingers who only had sex with women (heterosexual male swingers), and female swingers. Rectal symptoms were defined as any of the following: rectal discharge, bleeding, pain, redness, burning sensation, or itch. Anal sex included insertive anal sex, receptive anal sex, or both. Age (G32, 32Y45, 945 years) and number of sex partners in the past 6 months (G3, 3Y8, 98) were categorized into 3 groups, both based on tertile distributions. HIV status was defined as (tested) positive or tested negative. Syphilis status was defined as positive or negative, based on the presence or absence of TPHA.
Statistical Analysis
Prevalences of CT, NG, and CT and/or NG (CT/NG) were calculated by dividing the number of positive tests by the total number of tests multiplied by 100. Prevalences of urogenital, anorectal, and oropharyngeal CT/NG were stratified and compared between risk group categories using the W 2 test. Prevalence of anorectal CT/NG was further stratified for self-reported anal sex (yes/no), rectal symptoms (yes/no), and the combination of self-reported anal sex and/or rectal symptoms (yes/no), using the W 2 test. The proportion detected (sensitivity) by symptom-and sexual historyYbased (selective) testing was assessed by dividing the number of anorectal CT/NG found by symptom-and sexual historyY based testing by the number of anorectal CT/NG found by universal testing and multiplied by 100. The proportion CT/ NG missed by symptom-and sexual historyYbased testing was calculated by dividing the number of anorectal CT/NG without anal sex or rectal symptoms by the total number of anorectal CT/NG found by universal testing multiplied by 100. A P value G0.05 was considered statistically significant. Analyses were performed using SPSS version 17.0.0 (IBM Inc., Somers, NY).
RESULTS

Baseline Characteristics
We 
Chlamydia and Gonorrhoea Prevalence and Associated Determinants After Universal Testing
Prevalences of overall CT, NG, and CT/NG varied by risk group category (Table 2) . Multiple-site infections (i.e., both anorectal and oropharyngeal) were scarcely observed (in 15 consultations). Prevalence of oropharyngeal CT/NG ranged by risk group category from 2.0% to 5.1% (P = 0.46), prevalence of urogenital CT/NG ranged from 4.5% to 7.2% (P = 0.42), and prevalence of anorectal CT/NG differed by risk group category (Table 3) . Prevalence of anorectal CT/NG was higher in consults with reported rectal symptoms (27.6%) compared with consults without (7.5%; P G 0.001). Prevalence of anorectal CT/NG did not differ between consults with self-reported anal sex (9.6%) and no self-reported anal sex (7.3%; P = 0.09). Prevalence also did not differ by the presence or absence of the combination of anal sex and/or rectal symptoms (9.6% vs.7.3%; P = 0.09). In only 11 (0.7%; confidence interval [CI], 0.4%Y1.2%) consults, a CT/NG coinfection was diagnosed.
Anorectal Chlamydia/Gonorrhoea Infections Missed in Standard Symptom-and sexual historyYBased Testing
The overall proportion of anorectal CT/NG missed in symptom-and sexual historyYbased testing compared with nonselective, universal testing was 51.1% (71/139; CI, 43%Y59%) ( Table 3 ). Sensitivity of symptom-and sexual historyYbased testing for anorectal CT/NG differed across groups: 51.8% in homosexual MSM, 40.0% in bisexual MSM, 42.9% in bisexual male swingers, 40.0% in heterosexual male swingers, and 47.1% in female swingers (Table 3) 
DISCUSSION
In MSM and female and male swingers, sensitivity of symptom-and sexual historyYbased testing for detection of anorectal CT/NG was low. Prevalence of anorectal CT/NG was highest in MSM (11%Y12%) and female swingers (7%), and the highest numbers of missed CT/NG were in these risk groups (49%Y60% in MSM, 53% in female swingers).
These findings add to the growing body of evidence supporting universal testing in MSM 7 and strongly suggest that universal testing may also be warranted for female swingers. Although literature on universal anorectal testing in women is scarce, our findings are supported by Barry et al., 9 who found that 80% of the women who tested positive for anorectal CT did not report anal sex. Presence of anorectal CT/NG in those men and women without a history of self-reported anal sex may be explained by underreporting or alternative transmission routes not captured by routine history taking, for example, anal-digital activity and use of sex toys. In women, autoinoculation by infected vaginal secretions 25 may also be a possibility, although scientific evidence for this is scarce.
Because using self-report of sexual behavior as indication for selective testing may be problematic, so is the use of selfreported symptoms. Several studies suggest that anorectal CT infections most often are asymptomatic 1, 11 ; in our study, the prevalence of self-reported symptoms was very low (5%).
Our study has several limitations. First, we had no sexual history data distinguishing between receptive and insertive anal sex, preventing us from performing analyses accounting for this difference. Limiting testing to those reporting receptive anal sex may yield a high prevalence of anorectal CT/NG in this selected group. However, as our study shows, this approach would likely be overselective, leading to even larger proportions of missed anorectal CT/NG.
Second, data on self-reported condom use were unreliable because of a high proportion of missing values in our records. Thus, we were unable to assess the association between condom use and anorectal CT/NG. A study by Tian et al. 26 in the United States showed that condom use among heterosexuals practicing anal sex was low; 63% never used a condom during anal sex. Data from a surveillance study in the Netherlands revealed that 69% of women did not use a condom during their last anal sexual contact with a casual partner; for men, this was 45%. 27 Third, although our instructions on specimen collection were clear, 23 we cannot entirely rule out the possibility of specimen contamination, for example, via the urogenitalanorectal route.
Fourth, the sensitivity of different NAATs in testing of oropharyngeal and anorectal samples is under discussion. 23, 28 Sensitivity of strand displacement amplification and PCR was, in some studies, 14, 28 lower compared with other tests; this could have led to an underestimation of CT/NG infections.
In conclusion, our data show low sensitivity of symptomand sexual historyYbased testing for detection of anorectal CT/ NG in high-risk groups. Therefore, CT/NG control should include universal anorectal testing in MSM and female swingers for early detection and treatment of CT and NG to prevent medical complications and reduce further transmission.
